Urinary volatile organic compound metabolites and reduced lung function in U.S. adults.


Journal

Respiratory medicine
ISSN: 1532-3064
Titre abrégé: Respir Med
Pays: England
ID NLM: 8908438

Informations de publication

Date de publication:
12 2022
Historique:
received: 13 09 2022
revised: 07 11 2022
accepted: 09 11 2022
pubmed: 19 11 2022
medline: 15 12 2022
entrez: 18 11 2022
Statut: ppublish

Résumé

Volatile organic compounds (VOCs) are associated with adverse respiratory outcomes at high occupational exposures. However, whether exposure levels found in the general population have similar effects is unknown. We analyzed data on 1342 adult participants in the 2011-2012 National Health and Nutrition Examination Survey aged ≥18 years old who had urinary VOC metabolites and spirometry measurements available. Linear regression models adjusting for covariates were fitted to estimate the associations of VOC exposures levels and spirometry outcomes, while accounting for survey design and sampling weights to generate nationally representative estimates. The urinary metabolites for xylene, acrylamide, acrolein, 1,3-butadiene, cyanide, toluene, 1-bromopropane, acrylonitrile, propylene oxide, styrene, ethylbenzene, and crotonaldehyde in our analysis were all detected in >75% of participants. Forced expiratory volume in 1 s (FEV This is the first study of a representative sample of the U.S. adult population to reveal associations of acrylonitrile, propylene oxide, and styrene urinary metabolites with reduced lung function at non-occupational exposures. Results also support previous evidence of acrylamide and acrolein's association with adverse respiratory outcomes.

Sections du résumé

BACKGROUND
Volatile organic compounds (VOCs) are associated with adverse respiratory outcomes at high occupational exposures. However, whether exposure levels found in the general population have similar effects is unknown.
METHODS
We analyzed data on 1342 adult participants in the 2011-2012 National Health and Nutrition Examination Survey aged ≥18 years old who had urinary VOC metabolites and spirometry measurements available. Linear regression models adjusting for covariates were fitted to estimate the associations of VOC exposures levels and spirometry outcomes, while accounting for survey design and sampling weights to generate nationally representative estimates.
RESULTS
The urinary metabolites for xylene, acrylamide, acrolein, 1,3-butadiene, cyanide, toluene, 1-bromopropane, acrylonitrile, propylene oxide, styrene, ethylbenzene, and crotonaldehyde in our analysis were all detected in >75% of participants. Forced expiratory volume in 1 s (FEV
CONCLUSIONS
This is the first study of a representative sample of the U.S. adult population to reveal associations of acrylonitrile, propylene oxide, and styrene urinary metabolites with reduced lung function at non-occupational exposures. Results also support previous evidence of acrylamide and acrolein's association with adverse respiratory outcomes.

Identifiants

pubmed: 36399896
pii: S0954-6111(22)00318-3
doi: 10.1016/j.rmed.2022.107053
pmc: PMC9869342
mid: NIHMS1850816
pii:
doi:

Substances chimiques

Volatile Organic Compounds 0
propylene oxide Y4Y7NYD4BK
Acrylamide 20R035KLCI
Styrene 44LJ2U959V

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

107053

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL132344
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES027815
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES034049
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES006096
Pays : United States
Organisme : NIEHS NIH HHS
ID : R21 ES032161
Pays : United States
Organisme : NIDA NIH HHS
ID : K01 DA044313
Pays : United States
Organisme : NHGRI NIH HHS
ID : R01 HG011411
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no conflict of interest to disclose.

Références

Environ Res. 2020 Apr;183:108944
pubmed: 31911000
IARC Monogr Eval Carcinog Risks Hum. 1994;60:1-560
pubmed: 7869568
Ann Allergy Asthma Immunol. 2022 Sep;129(3):327-334
pubmed: 35595004
Food Chem Toxicol. 2019 Jul;129:38-53
pubmed: 31009736
Multidiscip Respir Med. 2019 Oct 02;14:33
pubmed: 31592111
Int J Chron Obstruct Pulmon Dis. 2019 Jul 12;14:1527-1537
pubmed: 31371938
Mol Nutr Food Res. 2011 Sep;55(9):1342-60
pubmed: 21994168
Environ Health Perspect. 2005 Feb;113(2):192-200
pubmed: 15687057
Toxicol Sci. 2005 Jan;83(1):177-89
pubmed: 15483188
Int J Environ Res Public Health. 2020 Dec 02;17(23):
pubmed: 33276576
Toxicol Ind Health. 2008 Sep;24(8):543-64
pubmed: 19039083
Int J Toxicol. 2020 Mar/Apr;39(2):93-102
pubmed: 32013673
Anal Chim Acta. 2012 Oct 31;750:152-60
pubmed: 23062436
Int J Occup Environ Health. 2000 Jan-Mar;6(1):1-8
pubmed: 10637531
Chemosphere. 2022 May;295:133880
pubmed: 35150700
Circulation. 2018 May 22;137(21):2295-2297
pubmed: 29784682
Environ Int. 2020 Dec;145:106121
pubmed: 32947160
Int J Hyg Environ Health. 2000 Mar;203(1):23-8
pubmed: 10956586
Int J Hyg Environ Health. 2001 Dec;204(4):211-21
pubmed: 11833293
Environ Sci Technol. 2015 Jun 2;49(11):6419-29
pubmed: 26000896
Chem Res Toxicol. 2009 Jun;22(6):1018-25
pubmed: 19522547
Atmos Environ (1994). 2011 Sep;45(28):4858-4867
pubmed: 25705111
Am J Epidemiol. 1997 Dec 1;146(11):939-48
pubmed: 9400335
Thorax. 2012 Aug;67(8):682-8
pubmed: 22436169
Regul Toxicol Pharmacol. 2021 Jun;122:104896
pubmed: 33617939
Am J Transl Res. 2017 Sep 15;9(9):4227-4235
pubmed: 28979696
PLoS One. 2014 May 09;9(5):e96926
pubmed: 24816802
Eur Respir J. 2022 Nov 17;60(5):
pubmed: 36202413
J Environ Sci Health B. 2019;54(9):745-751
pubmed: 31264935
Toxicol Sci. 2007 Jan;95(1):37-62
pubmed: 17062723
Am Rev Respir Dis. 1991 Mar;143(3):516-21
pubmed: 2001060
Acta Histochem. 2019 Jul;121(5):595-603
pubmed: 31109687
Am J Respir Crit Care Med. 1999 Jan;159(1):179-87
pubmed: 9872837
Am J Clin Nutr. 2009 Mar;89(3):773-7
pubmed: 19158207
Endocrinologie. 1990 Jul-Dec;28(3-4):187-92
pubmed: 2103974
Sci Total Environ. 2021 Jul 15;778:146304
pubmed: 34030393
Environ Pollut. 2022 Jan 1;292(Pt B):118469
pubmed: 34752792
Front Immunol. 2020 Oct 09;11:1940
pubmed: 33162970
Am J Ind Med. 2017 Feb;60(2):163-180
pubmed: 28079275
Toxicol Appl Pharmacol. 1984 Mar 15;72(3):495-503
pubmed: 6710500
Prim Care Respir J. 2013 Mar;22(1):PS9-15
pubmed: 23460017
Arch Environ Occup Health. 2022;77(7):576-585
pubmed: 34545769

Auteurs

Angelico Mendy (A)

Division of Epidemiology, Department of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Electronic address: angelico.mendy@uc.edu.

Sara Burcham (S)

Division of Epidemiology, Department of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Ashley L Merianos (AL)

School of Human Services, University of Cincinnati, Cincinnati, OH, USA.

Tesfaye B Mersha (TB)

Division of Asthma Research, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

E Melinda Mahabee-Gittens (EM)

Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Aimin Chen (A)

Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Kimberley Yolton (K)

General and Community Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH